Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Type_97_Te-Ke_(Improved)
|
| gptkbp:affects |
Insulin sensitivity
|
| gptkbp:associated_with |
Obesity
|
| gptkbp:can_lead_to |
Cardiovascular disease
|
| gptkbp:community_support |
Support groups
Online forums Health coaching |
| gptkbp:complications |
Kidney damage
Skin conditions Neuropathy Retinopathy Foot damage |
| gptkbp:education |
Patient education
Public awareness campaigns |
| gptkbp:future_plans |
Long-term outcomes
New medications Technology in diabetes management |
| https://www.w3.org/2000/01/rdf-schema#label |
Type 2 Ke-Ni
|
| gptkbp:impact |
gptkb:Anxiety
gptkb:Depression Stress management |
| gptkbp:influenced_by |
Behavioral therapy
Increased physical activity Dietary modifications |
| gptkbp:is_monitored_by |
Cholesterol levels
Blood pressure monitoring A1 C testing Regular blood sugar checks |
| gptkbp:is_popular_in |
Increasing
|
| gptkbp:is_protected_by |
Regular exercise
Weight management Healthy diet |
| gptkbp:managed_by |
Diet and exercise
|
| gptkbp:number_of_teams |
Affects millions worldwide
Associated with economic burden Higher prevalence in certain ethnic groups |
| gptkbp:provides_information_on |
gptkb:healthcare_organization
gptkb:World_Health_Organization |
| gptkbp:research_focus |
Genetic factors
Lifestyle interventions Pharmacological treatments |
| gptkbp:risk_factor |
Family history
Physical inactivity Age over 45 |
| gptkbp:social_responsibility |
Blood tests
|
| gptkbp:symptoms |
Fatigue
Blurred vision Frequent urination Increased thirst |
| gptkbp:treatment |
gptkb:Metformin
Insulin therapy |